RXST Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

6.700

Open

6.240

VWAP

6.47

Vol

457.00K

Mkt Cap

274.01M

Low

6.070

Amount

2.96M

EV/EBITDA(TTM)

Total Shares

41.27M

45.97M

EV/OCF(TTM)

P/S(TTM)

2.02

RxSight, Inc. is a commercial-stage medical technology company engaged in providing customized vision to patients following cataract surgery. Its RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system is composed of RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and related accessories. The LAL is an intraocular lens (IOL) made from the silicone-based photosensitive material that undergoes controlled changes in refractive power when exposed to specific ultraviolet (UV) light patterns generated by the LDD. Its LAL uses a silicone formulation that enables changing the mechanical and optical properties of the lens following implantation. The LDD uses software and algorithms to deliver a short UV light exposure treatment that polymerizes specific portions of the lens and allows doctors to adjust spherical and cylindrical refraction.

Events Timeline

(ET)

2026-02-25

16:40:00

RxSight Reports Q4 Revenue of $32.61M, Exceeding Expectations

2026-02-25

16:40:00

Sees FY26 Operating Expenses at $150M-$160M

2026-01-12 (ET)

2026-01-12

09:00:00

Morgan Stanley Maintains RxSight Price Target at $10

2026-01-11 (ET)

2026-01-11

14:20:00

RxSight CEO Reports Significant Progress in Cataract Market

News

9.5

02-26seekingalpha

RxSight, Inc. Reports Q4 2025 Earnings with Strategic Insights

9.5

02-25seekingalpha

RxSight Issues 2026 Financial Guidance with Q4 Results

2.0

01-12Benzinga

U.S. Stocks Mixed; Day One Biopharmaceuticals Shares Surge 20%

7.5

01-12Benzinga

Planet Labs PBC Secures Nine-Figure Deal with Swedish Armed Forces, Shares Surge 7%

9.5

01-11NASDAQ.COM

RxSight Expects Q4 2025 Revenue of $32.6 Million, Appoints CFO

9.5

01-11Globenewswire

RxSight Reports $134.5M Revenue for 2025, Announces CFO Transition

9 Analyst Rating

Wall Street analysts forecast RXST stock price to rise

1 Buy

6 Hold

2 Sell

Hold

Current: 0.000

Low

8.00

Averages

10.25

High

14.00

Current: 0.000

Low

8.00

Averages

10.25

High

14.00

Stifel

Thomas Stephan

Hold

downgrade

$10 -> $9

AI Analysis

2026-03-09

Reason

Stifel

Thomas Stephan

Price Target

$10 -> $9

AI Analysis

2026-03-09

downgrade

Hold

Reason

Stifel analyst Thomas Stephan lowered the firm's price target on RxSight to $9 from $10 and keeps a Hold rating on the shares. The firm updated models across its medical technology and supplies coverage following Q4 reporting from the group.

UBS

Danielle Antalffy

Neutral

maintain

$8 -> $9

2026-02-26

Reason

UBS

Danielle Antalffy

Price Target

$8 -> $9

2026-02-26

maintain

Neutral

Reason

UBS analyst Danielle Antalffy raised the firm's price target on RxSight to $9 from $8 and keeps a Neutral rating on the shares. The lower 2026 outlook should limit downside risk, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for RXST

Unlock Now

Valuation Metrics

The current forward P/E ratio for Rxsight Inc (RXST.O) is 116.28, compared to its 5-year average forward P/E of -17.26. For a more detailed relative valuation and DCF analysis to assess Rxsight Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-17.26

Current PE

116.28

Overvalued PE

33.00

Undervalued PE

-67.52

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-25.57

Current EV/EBITDA

-5.30

Overvalued EV/EBITDA

3.50

Undervalued EV/EBITDA

-54.64

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

7.78

Current PS

1.90

Overvalued PS

11.50

Undervalued PS

4.05

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

list of stocks beat suited for sell put

Intellectia · 13 candidates

Relative Vol: >= 1.50Current Ratio: >= 1.50Debt Equity: <= 0.500Weekly Average Turnover: >= 2,000,000Is Optionable: TrueOption Sentiments: Bullish

Ticker

Name

Market Cap$

OR Royalties Inc

8.14B

GNTX

Gentex Corp

5.20B

CGON

CG Oncology Inc

4.61B

SII

Sprott Inc

3.27B

PLAB

Photronics Inc

2.14B

UAMY

United States Antimony Corp

1.28B

show me these stocks

Intellectia · 24 candidates

Price: $0.05 - $20.00Relative Vol: >= 1.50Beta: HighRiskWeekly Average Turnover: >= 1,000,000Shares Outstanding: <= 50,000,000

Ticker

Name

Market Cap$

KRNT

Kornit Digital Ltd

649.13M

FCEL

Fuelcell Energy Inc

446.34M

RXST

Rxsight Inc

409.11M

TARA

Protara Therapeutics Inc

309.20M

OSS

One Stop Systems Inc

286.10M

MEI

Methode Electronics Inc

267.33M

I mean the lowest priced stock

Intellectia · 24 candidates

Price: <= $10.00Relative Vol: >= 1.50Gap Pattern: GapDownMoving Average Relationship: PriceCrossAboveMA5Candlestick Pattern: InverseHeadAndShoulder, WhiteCandlestick

Ticker

Name

Market Cap$

RXST

Rxsight Inc

409.11M

So-Young International Inc

305.89M

OABI

OmniAb Inc

289.35M

FNKO

Funko Inc

211.27M

NAMM

Namib Minerals

121.31M

MGLD

Marygold Companies Inc

53.85M

What stock to buy for short term?

Intellectia · 28 candidates

Relative Vol: >= 1.50Beta: HighRiskWeekly Average Turnover: >= 1,000,000Rsi 14: 40 - 60Week Price Change Pct: >= $2.00

Ticker

Name

Market Cap$

ARM

Arm Holdings PLC

120.87B

Nu Holdings Ltd

83.54B

MOG.A

Moog Inc

9.94B

GME

GameStop Corp

9.72B

Quantumscape Corp

6.64B

TGS

Transportadora de Gas del Sur SA

4.61B

Whales Holding RXST

RA Capital Management, L.P.

Trading Trends

People Also Watch

Frequently Asked Questions

What is Rxsight Inc (RXST) stock price today?

The current price of RXST is 6.64 USD — it has increased 4.73

What is Rxsight Inc (RXST)'s business?

What is the price predicton of RXST Stock?

Wall Street analysts forecast RXST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RXST is10.25 USD with a low forecast of 8.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Rxsight Inc (RXST)'s revenue for the last quarter?

Rxsight Inc revenue for the last quarter amounts to 32.61M USD, decreased -18.91

What is Rxsight Inc (RXST)'s earnings per share (EPS) for the last quarter?

Rxsight Inc. EPS for the last quarter amounts to -0.22 USD, increased 46.67

How many employees does Rxsight Inc (RXST). have?

Rxsight Inc (RXST) has 461 emplpoyees as of April 05 2026.

What is Rxsight Inc (RXST) market cap?

Today RXST has the market capitalization of 274.01M USD.

RXST Overview

RXST Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding RXST

Trading Trends

People Also Watch

Frequently Asked Questions

What is Rxsight Inc (RXST) stock price today?

What is Rxsight Inc (RXST)'s business?

What is the price predicton of RXST Stock?

What is Rxsight Inc (RXST)'s revenue for the last quarter?

What is Rxsight Inc (RXST)'s earnings per share (EPS) for the last quarter?

How many employees does Rxsight Inc (RXST). have?

What is Rxsight Inc (RXST) market cap?